BIOMAT Database Logo BIOMAT Database Logo

A central 6-hydroxydopamine lesion prevents fluphenazine-induced increase in plasma homovanillic acid. 1988

R Labarca, and J W Thomas, and M Koulu, and Y S Kim, and A Janowsky, and L Wilkinson, and M Linnoila, and S M Paul, and D Pickar
Clinical Neuroscience Branch, National Institute of Mental Health, Bethesda, MD 20892.

Plasma and brain levels of the dopamine metabolite, homovanillic acid, were measured in rats after acute and chronic treatment with fluphenazine. After acute administration, homovanillic acid levels were increased in the whole frontal cortex, caudate nucleus, nucleus accumbens, anterior cingulate (supragenual) cortex, prefrontal cortex and plasma. Following chronic administration, the effects of single doses of fluphenazine in increasing homovanillic acid were markedly attenuated in the caudate nucleus, nucleus accumbens, the whole frontal cortex, anterior cigulate cortex and plasma, but not in the prefrontal (anteromedial) cortex. Following fluphenazine administration plasma homovanillic acid levels were correlated with homovanillic acid concentrations in whole frontal cortex (r = 0.63, p less than 0.01) and caudate nucleus (r = 0.51, p less than 0.05). Further, prior intracerebroventricular administration of 6-hydroxydopamine prevented the fluphenazine-induced increase in plasma homovanillic acid. These data suggest that in the rat, plasma and brain (caudate nucleus and whole frontal cortex) homovanillic acid levels change in a similar fashion during acute and chronic neuroleptic administration.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008297 Male Males
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005476 Fluphenazine A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE. Flufenazin,Fluphenazine Hydrochloride,Lyogen,Prolixin,Hydrochloride, Fluphenazine
D005625 Frontal Lobe The part of the cerebral hemisphere anterior to the central sulcus, and anterior and superior to the lateral sulcus. Brodmann Area 8,Brodmann's Area 8,Frontal Cortex,Frontal Eye Fields,Lobus Frontalis,Supplementary Eye Field,Area 8, Brodmann,Area 8, Brodmann's,Brodmanns Area 8,Cortex, Frontal,Eye Field, Frontal,Eye Field, Supplementary,Eye Fields, Frontal,Frontal Cortices,Frontal Eye Field,Frontal Lobes,Lobe, Frontal,Supplementary Eye Fields
D006719 Homovanillic Acid A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid. 3-Methoxy-4-Hydroxyphenylacetic Acid,4-Hydroxy-3-Methoxyphenylacetic Acid,3 Methoxy 4 Hydroxyphenylacetic Acid,4 Hydroxy 3 Methoxyphenylacetic Acid,Acid, 3-Methoxy-4-Hydroxyphenylacetic,Acid, 4-Hydroxy-3-Methoxyphenylacetic,Acid, Homovanillic

Related Publications

R Labarca, and J W Thomas, and M Koulu, and Y S Kim, and A Janowsky, and L Wilkinson, and M Linnoila, and S M Paul, and D Pickar
Plasma homovanillic acid as a predictor of response to fluphenazine treatment.
January 1989, Psychopharmacology bulletin,
R Labarca, and J W Thomas, and M Koulu, and Y S Kim, and A Janowsky, and L Wilkinson, and M Linnoila, and S M Paul, and D Pickar
Brain contribution to the haloperidol-induced increase in plasma homovanillic acid.
May 1981, European journal of pharmacology,
R Labarca, and J W Thomas, and M Koulu, and Y S Kim, and A Janowsky, and L Wilkinson, and M Linnoila, and S M Paul, and D Pickar
Central muscarinic receptor degeneration following 6-hydroxydopamine lesion in mice.
January 1980, Life sciences,
R Labarca, and J W Thomas, and M Koulu, and Y S Kim, and A Janowsky, and L Wilkinson, and M Linnoila, and S M Paul, and D Pickar
Guanosine prevents depressive-like behaviors in rats following bilateral dorsolateral striatum lesion induced by 6-hydroxydopamine.
October 2019, Behavioural brain research,
R Labarca, and J W Thomas, and M Koulu, and Y S Kim, and A Janowsky, and L Wilkinson, and M Linnoila, and S M Paul, and D Pickar
Chemical sympathectomy with 6-hydroxydopamine potentiates intracerebroventricularly applied bombesin-induced increase in plasma adrenaline.
January 1991, Life sciences,
R Labarca, and J W Thomas, and M Koulu, and Y S Kim, and A Janowsky, and L Wilkinson, and M Linnoila, and S M Paul, and D Pickar
Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia.
June 1990, Archives of general psychiatry,
R Labarca, and J W Thomas, and M Koulu, and Y S Kim, and A Janowsky, and L Wilkinson, and M Linnoila, and S M Paul, and D Pickar
Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian rats.
November 2005, Journal of neurochemistry,
R Labarca, and J W Thomas, and M Koulu, and Y S Kim, and A Janowsky, and L Wilkinson, and M Linnoila, and S M Paul, and D Pickar
Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra.
January 2001, Brain research,
R Labarca, and J W Thomas, and M Koulu, and Y S Kim, and A Janowsky, and L Wilkinson, and M Linnoila, and S M Paul, and D Pickar
Increase of brain homovanillic acid level induced by metoclopramide.
January 1975, Neuropharmacology,
R Labarca, and J W Thomas, and M Koulu, and Y S Kim, and A Janowsky, and L Wilkinson, and M Linnoila, and S M Paul, and D Pickar
Nisoxetine prevents the 6-hydroxydopamine induced decrease in post-decapitation convulsions.
January 1977, Life sciences,
Copied contents to your clipboard!